Arrowhead Pharmaceuticals Inc.

+1.59 (+3.48%)
Earnings Announcements

Arrowhead Pharmaceuticals Inc - QTRLY Net Loss Per Share (Diluted)$0.68

Published: 08/04/2022 20:42 GMT
Arrowhead Pharmaceuticals Inc. (ARWR) - Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results.
Qtrly Revenue $32.41 Million Versus $45.89 Million.
Qtrly Net Loss per Share (diluted)$0.68.
Q3 Earnings per Share View $-0.51, Revenue View $55.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $66.91 Million
Adjusted EPS is expected to be -$0.39

Next Quarter Revenue Guidance is expected to be $62.03 Million
Next Quarter EPS Guidance is expected to be -$0.50

More details on our Analysts Page.